Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra S Diebold

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggeringAlexander D Edwards, Shivanthi P Manickasingham, Roman Spörri, et al.
Nature|June 24, 2003
Viral infection switches non-plasmacytoid dendritic cells into high interferon producersSandra S Diebold, Maria Montoya, Hermann Unger, et al.
Biomaterials|August 1, 2016
Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapyHatem A F M Hassan, Lesley Smyth, Julie T-W Wang, et al.
Nature|February 16, 2005
Toll-like receptor 3 promotes cross-priming to virus-infected cellsOliver Schulz, Sandra S Diebold, Margaret Chen, et al.
Plos One|June 4, 2011
Monitoring of in vivo function of superparamagnetic iron oxide labelled murine dendritic cells during anti-tumour vaccinationRichard Tavaré, Pervinder Sagoo, Gopal Varama, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 24, 2016
Carbon nanotubes' surface chemistry determines their potency as vaccine nanocarriers in vitro and in vivoHatem A F M Hassan, Lesley Smyth, Noelia Rubio, et al.
Plos One|April 15, 2017
Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinomaEva Brencicova, Ann L Jagger, Hayley G Evans, et al.
Nature Communications|July 29, 2018
Macrophages are exploited from an innate wound healing response to facilitate cancer metastasisTamara Muliaditan, Jonathan Caron, Mary Okesola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2018
Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of CancerTamara Muliaditan, James W Opzoomer, Jonathan Caron, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggeringAlexander D Edwards, Shivanthi P Manickasingham, Roman Spörri, et al.
Nature|June 24, 2003
Viral infection switches non-plasmacytoid dendritic cells into high interferon producersSandra S Diebold, Maria Montoya, Hermann Unger, et al.
Biomaterials|August 1, 2016
Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapyHatem A F M Hassan, Lesley Smyth, Julie T-W Wang, et al.
Nature|February 16, 2005
Toll-like receptor 3 promotes cross-priming to virus-infected cellsOliver Schulz, Sandra S Diebold, Margaret Chen, et al.
Plos One|June 4, 2011
Monitoring of in vivo function of superparamagnetic iron oxide labelled murine dendritic cells during anti-tumour vaccinationRichard Tavaré, Pervinder Sagoo, Gopal Varama, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 24, 2016
Carbon nanotubes' surface chemistry determines their potency as vaccine nanocarriers in vitro and in vivoHatem A F M Hassan, Lesley Smyth, Noelia Rubio, et al.
Plos One|April 15, 2017
Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinomaEva Brencicova, Ann L Jagger, Hayley G Evans, et al.
Nature Communications|July 29, 2018
Macrophages are exploited from an innate wound healing response to facilitate cancer metastasisTamara Muliaditan, Jonathan Caron, Mary Okesola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2018
Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of CancerTamara Muliaditan, James W Opzoomer, Jonathan Caron, et al.
Pageof 3